Skip Navigation

Cardiovascular Research 2000 47(3):537-548; doi:10.1016/S0008-6363(00)00018-3
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cuzzocrea, S.
Right arrow Articles by Caputi, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuzzocrea, S.
Right arrow Articles by Caputi, A. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury

Salvatore Cuzzocreaa,*, Emanuela Mazzonb, Giuseppina Costantinoa, Ivana Serrainoa, Angela De Sarroa and Achille P. Caputia

aInstitute of Pharmacology, School of Medicine, University of Messina, Torre Biologica–Policlinico Universitario, Via C. Valeria–Gazzi, 98100 Messina, Italy
bDepartment of Biomorphology, School of Medicine, University of Messina, Torre Biologica–Policlinico Universitario, Via C. Valeria–Gazzi, 98100 Messina, Italy

* Corresponding author. Tel.: +39-90-221-3644; fax: +39-90-694-951 salvator{at}www.unime.it

Objective: Splanchnic artery occlusion shock (SAO) causes an enhanced formation of reactive oxygen species (ROS), which contribute to the pathophysiology of shock. Here we have investigated the effects of n-acetylcysteine (NAC), a free radical scavenger, in rats subjected to SAO shock. Methods and results: Treatment of rats with NAC (applied at 20 mg/kg, 5 min prior to reperfusion, followed by an infusion of 20 mg/kg/h) attenuated the mean arterial blood and the migration of polymorphonuclear cells (PMNs) caused by SAO-shock. NAC also attenuated the ileum injury (histology) as well as the increase in the tissue levels of myeloperoxidase (MPO) and malondialdehyde (MDA) caused by SAO shock in the ileum. There was a marked increase in the oxidation of dihydrorhodamine 123 to rhodamine in the plasma of the SAO-shocked rats after reperfusion. Immunohistochemical analysis for nitrotyrosine and for poly(ADP-ribose) synthetase (PARS) revealed a positive staining in ileum from SAO-shocked rats. The degree of staining for nitrotyrosine and PARS were markedly reduced in tissue sections obtained from SAO-shocked rats which had received NAC. Reperfused ileum tissue sections from SAO-shocked rats showed positive staining for P-selectin, which was mainly localised in the vascular endothelial cells. Ileum tissue section obtained from SAO-shocked rats with anti-intercellular adhesion molecule (ICAM-1) antibody showed a diffuse staining. NAC treatment markedly reduced the intensity and degree of P-selectin and ICAM-1 in tissue section from SAO-shocked rats. In addition, in ex vivo studies in aortic rings from shocked rats, we found reduced contractions to noradrenaline and reduced responsiveness to a relaxant effect to acetylcholine (vascular hyporeactivity and endothelial dysfunction, respectively). NAC treatment improved contractile responsiveness to noradrenaline, enhanced the endothelium-dependent relaxations and significantly improved survival. Conclusion: Taken together, our results clearly demonstrate that NAC treatment exert a protective effect and part of this effect may be due to inhibition of the expression of adhesion molecule and peroxynitrite-related pathways and subsequent reduction of neutrophil-mediated cellular injury.

KEYWORDS ICAM-1, intercellular adhesion molecule; iNOS, inducible nitric oxide synthase; NAC, n-acetylcysteine; MDA, malonaldehyde; MPO, myeloperoxidase; NO, nitric oxide; PBS, phosphate-buffered saline; PMN, polymorphonuclear leukocyte; SAO, splanchnic artery occlusion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
Muhammad Anees Sharif, U. Bayraktutan, I. S. Young, and Chee Voon Soong
N-Acetylcysteine Does Not Improve the Endothelial and Smooth Muscle Function in the Human Saphenous Vein
Vascular and Endovascular Surgery, July 1, 2007; 41(3): 239 - 245.
[Abstract] [PDF]


Home page
Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. de Araujo, L. Andrade, T. M. Coimbra, A. C. Rodrigues Jr, and A. C. Seguro
Magnesium Supplementation Combined with N-Acetylcysteine Protects against Postischemic Acute Renal Failure
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3339 - 3349.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
V. G. Nielsen and J. P. Crow
Peroxynitrite Decreases Rabbit Tissue Factor Activity In Vitro
Anesth. Analg., March 1, 2004; 98(3): 668 - 671.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Song, J. A. Kellum, H. Kaldas, and M. P. Fink
Evidence That Glutathione Depletion Is a Mechanism Responsible for the Anti-Inflammatory Effects of Ethyl Pyruvate in Cultured Lipopolysaccharide-Stimulated RAW 264.7 Cells
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 307 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Ding-Zhou, C. Marchand-Verrecchia, B. Palmier, N. Croci, P.-E. Chabrier, M. Plotkine, and I. Margaill
Neuroprotective Effects of (S)-N-[4-[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl]-2-thiophenecarboximid-amide (BN 80933), an Inhibitor of Neuronal Nitric-Oxide Synthase and an Antioxidant, in Model of Transient Focal Cerebral Ischemia in Mice
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 588 - 594.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Virag and C. Szabo
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Pharmacol. Rev., September 1, 2002; 54(3): 375 - 429.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
E. M. Bulger and R. V. Maier
Antioxidants in Critical Illness
Arch Surg, October 1, 2001; 136(10): 1201 - 1207.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.